The nature of SARS-CoV-2 testing has changed. Where antibody tests were once chiefly used for charting the spread of infection within communities, today it is emerging as a key pillar of large-scale immunisation campaigns.

The webinar will present new data demonstrating the key roles antibody testing has to play. The data will foster discussions on understanding longevity of immunity and provide the opportunity to examine the rationale of pre-screening people for antibodies prior to vaccination.

The data will enable examination of antibody vaccine response using rapid neutralising antibody tests.

Benefits of attending:

  • Learn about the importance of neutralising rapid antibody detection and vaccine role out
  • Gain insight into how patients respond to COVID-19 vaccines
  • Discover the longevity of neutralising antibodies following infection with SARS-CoV-2 virus
  • Review the performance characteristics and usability of rapid antibody tests


Who should attend the webinar:

  • Healthcare professionals
  • Clinical trial leaders
  • Public sector organisations looking to monitor their workforce’s immunity
  • Companies seeking information on their ‘return to work’ strategy

Featured Speakers

Professor Lawrence S. Young

Virologist and Pro-Dean for External Affairs at Warwick Medical School and Director of the Warwick Cancer Research Centre, UK

Internationally recognised for his work in virus infection, Professor Young was appointed as a Pro-Vice Chancellor at the University of Warwick in January 2013 with responsibility for strategic planning and resources. In 2016 he became Vice-President at the University of Warwick, encompassing his existing responsibilities, while highlighting his leadership in the University’s engagement activities in China and Hong Kong. In 2018 Professor Young was appointed as Pro-Dean for External Affairs at Warwick Medical School and Director of the Warwick Cancer Research Centre.

Professor Mark Drayson

Clinical Immunologist at University of Birmingham, UK

Professor of Clinical Immunodiagnostics and Director of the Clinical Immunology Service (CIS), College of Medical and Dental Sciences at the University of Birmingham. He graduated with his Medical Degree from the University of Manchester in 1980 and gained his PhD there in Immunology in 1987. He worked in Birmingham from 1990 as Clinical Lecturer in Immunology. He obtained Membership to the Royal College of Pathologists in 1993 and became a Fellow in 2001.

Professor Tara Moore

Professor of Personalised Medicine, Ulster University, NI

Tara Moore, Professor of Personalised Medicine, holds a chair at Ulster University in Northern Ireland where her research team concentrate on partner diagnostics and therapeutics for genetic disease. Her work is disseminated worldwide through her contribution to guest lectures and workshops and internationally co-authored peer reviewed publications. Tara has contributed to numerous textbooks and authored over 150 publications in high impact peer reviewed journals reflecting internationally competitive research of high quality with 3790 total citations, h-index of 33 and i10-index of 72.

Nina Garrett

R&D Director
Abingdon Health

Nina joined Abingdon Health in 2019 and brought with her over 18 years of experience in the development and production of lateral flow rapid tests. Nina held several senior roles at British Biocell International (now BBI Group) before moving to oversee Abingdon Health’s assay development and technical transfer teams.

Nina has a Masters in Chemistry (MChem) from the University of Exeter.

NOW AVAILABLE ON-DEMAND

NOW AVAILABLE ON-DEMAND